Relationship Between Cardiometabolic Index and Insulin Resistance in Patients with Type 2 Diabetes
Limin Wu,Jing Xu
DOI: https://doi.org/10.2147/dmso.s449374
2024-01-24
Diabetes Metabolic Syndrome and Obesity Targets and Therapy
Abstract:Limin Wu, 1 Jing Xu 2 1 Department of Gastroenterology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Lucheng District, Wenzhou, Zhejiang Province, People's Republic of China; 2 Department of Endocrinology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Lucheng District, Wenzhou, Zhejiang Province, People's Republic of China Correspondence: Jing Xu, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, People's Republic of China, Tel +86 15068256508, Email Purpose: Cardiometabolic index (CMI) has been suggested as innovative measures for assessing the cardiometabolic status. However, there is a lack of relevant studies on exploring the relationship between CMI and insulin resistance (IR). Consequently, this study aims to examine the relationship between CMI and IR in subjects with type 2 diabetes mellitus (T2DM). Patients and Methods: A cross-sectional study was performed on 2493 patients with T2DM (including 1505 males and 988 females). IR was measured through the homeostatic model assessment of insulin resistance (HOMA-IR), which was defined as HOMI-IR≥ 2.69. The relationship between CMI and IR was evaluated with Spearman's correlation, ROC analysis, multiple logistic regression, generalized smooth curve fitting and subgroup analysis. Results: CMI was correlated with HOMA-IR in patients with T2DM (Spearman correlation coefficient = 0.391 in females and 0.346 in males, P< 0.001). Through the multiple logistic regression analysis, CMI was significantly correlated with IR (OR=1.30, 95% CI=1.15– 1.47 in males and OR=1.62, 95% CI=1.32– 1.99 in females). In addition, a non-linear correlation between CMI and IR risk was identified. The AUC of CMI (AUC = 0.702 for males and 0.733 for females, all p < 0.01) was the largest compared with traditional indexes of adiposity and blood lipids. According to the subgroup analysis, the two had a more significantly positive correlation in females, the elderly and subjects with HbA1c < 7%. Conclusion: In patients with T2DM, elevated CMI is significantly correlated with IR, as a useful index of IR. Keywords: high density lipoprotein cholesterol, cardiometabolic index, waist-to-height ratio, insulin resistance, type 2 diabetes mellitus Given that IR is recognized as a prominent factor in various pathological conditions, including diabetes mellitus, atherosclerosis, hypertension and metabolic syndrome (MetS), it is imperative to accurately assess IR. The hyperinsulinemic-euglycemic clamp is considered as a gold standard for measuring IR in studies. 1 However, its practicality is limited for routine clinical use due to issues of replicability, cost and accessibility. 1–5 As a substitute, HOMA-IR is commonly employed in adults. 6 Nevertheless, the calculation of HOMA-IR necessitates the measurement of fasting plasma insulin, which is not typically performed in clinical settings. Therefore, an accurate, simple and cost-effective diagnostic test is needed to predict IR. The correlation between obesity, dyslipidemia and IR has been extensively documented in the literature. 7,8 Specifically, the TG/HDL-C ratio has emerged as a valuable index for predicting the susceptibility to NAFLD and effectively evaluating IR in NAFLD. 9–11 The Waist-to-height ratio (WHtR) is a composite measure that incorporates both height and waist circumference (WC). Compared with the conventional single-body measurement index, WHtR demonstrates superior capability in identifying abdominal obesity, assessing cardiac metabolic risk, IR and various noncommunicable diseases. 12–15 Recently, Wakabayashi et al introduced a novel index known as CMI. 16 CMI is calculated by multiplying WHtR with the TG/HDL-C ratio, thereby integrating lipid and obesity parameters into a straightforward and reproducible marker for the effective detection of NAFLD and diabetes. 16,17 Furthermore, a number of recent studies have demonstrated a strong relationship between CMI and various diseases affecting people's health conditions, such as stroke, hypertension, kidney diseases and cardiovascular diseases. 18–21 These findings suggest that CMI is of great values as an index for metabolic diseases. However, there is currently a lack of relevant studies on exploring potential links between CMI and IR. Therefore, this study aims to explore the relationship between IR and CMI in patients with T2DM through a comprehensive cross-sectional analysis and to determine whether CMI can be used as a novel and practical biomarker for diagnosing IR. In this cross-sectional study, 2493 patie -Abstract Truncated-
endocrinology & metabolism